XML 75 R59.htm IDEA: XBRL DOCUMENT
v3.10.0.1

BUSINESS CONCENTRATIONS (Details Narrative) - USD ($) | 12 Months Ended
--- | ---
Dec. 31, 2018 | Dec. 31, 2017 | Dec. 31, 2016
Concentration Risk [Line Items] |  |  |
Minimum purchase commitments for softgels | $ 2,600,000 |  |
Payment for minimum purchase quantities of purchase commitments (percent) | 50.00% |  |
Customer Concentration [Member] | Sales Revenue [Member] | Four Major Customers [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk | 76.00% | 59.00% |
Customer Concentration [Member] | Sales Revenue [Member] | Four Major Customers [Member] | Minimum [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk | 10.00% | 10.00% |
Customer Concentration [Member] | Sales Revenue [Member] | Three Major Customers [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk |  |  | 41.00%
Customer Concentration [Member] | Sales Revenue [Member] | Three Major Customers [Member] | Minimum [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk |  |  | 10.00%
Customer Concentration - Pillpack [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues | $ 5,075,000 |  |
Customer Concentration - AmerisourceBergen [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues | 3,246,000 | $ 2,667,000 |
Customer Concentration - Cardinal Health [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues | 2,308,000 | 2,559,000 |
Customer Concentration - McKesson Corp [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues | $ 1,610,000 | 1,959,000 |
Customer Concentration - Pharmacy Innovations, Pa [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues |  | $ 2,715,000 | $ 2,040,000
Customer Concentration - Woodstock Pharmaceutical and Compounding [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues |  |  | 2,247,000
Customer Concentration - Medical Center Pharmacy [Member] | Sales Revenue [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Revenues |  |  | $ 3,700,000
Products Supplier #1 [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk | 43.00% | 100.00% | 98.00%
Products Supplier #2 [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk | 33.00% |  |
Products Supplier #3 [Member] |  |  |
Concentration Risk [Line Items] |  |  |
Concentration Risk | 24.00% |  |

X
- Definition Percent payment we are required to pay of the difference between the total amount we would have paid to supplier if the minimum requirement had been fulfilled and the sum of all purchases of products from supplier during the contract year; if the minimum order quantities of specific products are not met, + References No definition available. + Details
Name: | txmd_PaymentForMinimumPurchaseQuantitiesOfPurchaseCommitmentsPercentage
Namespace Prefix: | txmd_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ConcentrationRiskLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13531-108611 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109250915&loc=d3e13537-108611 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592 + Details
Name: | us-gaap_ConcentrationRiskPercentage1
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 4 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=77896938&loc=d3e25336-109308 + Details
Name: | us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=txmd_FourMajorCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=txmd_ThreeMajorCustomersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk4Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk5Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk7Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk8Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_CustomerConcentrationRisk1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_SupplierConcentrationRiskOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ConcentrationRiskByTypeAxis=txmd_SupplierConcentrationRiskTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |